33.7 C
New York
Friday, June 12, 2026

Tag: recruitment

newssourceFORcompanyinformationcontent1marketreleases

HopeAI Joins Mayo Clinic Platform to Transform the Future of Drug Development with AI

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- HopeAI, an emerging leader in applying artificial intelligence (AI) to accelerate new drug development, has officially joined...

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sarepta To Contact Him Directly To Discuss Their Options

Sleep Health Week: Researchers Recruiting Now for CBD Insomnia Trial

During Sleep Health Week (11-15 August 2025), Australians living with insomnia are reminded that a new treatment is on the horizon – with clinical...

EQT to acquire South Korea’s leading AI-enabled HR Tech Platform, Remember

Remember has rapidly grown into a leading AI-powered HR tech platform used by the vast majority of South Korea's professional workforce, solidifying its position...

SRPT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline...

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

Boralex announces the departure of its Chief Financial Officer

MONTREAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) announces that Bruno Guilmette, Executive Vice President and Chief Financial Officer, has chosen to take on new challenges by accepting a new professional opportunity, after nearly seven years with the Company. He will remain as Chief Financial Officer until September 12, 2025, to ensure a smooth transition.

Boralex reports second quarter operating income comparable to 2024 and actively pursue its development and construction activities

MONTREAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Corporation”) (TSX: BLX) is pleased to report its results for the second quarter of 2025.

LUNDIN GOLD REPORTS SECOND QUARTER 2025 RESULTS

Exceptional operating performance drives record revenues and free cash flow VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Lundin Gold Inc.  (TSX: LUG) (Nasdaq Stockholm: LUG)...

LUNDIN GOLD DECLARES QUARTERLY DIVIDENDS OF US$0.79 PER SHARE

VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased...

Sarepta Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses

Harvia’s Half-year financial review 1 January – 30 June 2025

Harvia Plc, Half-year financial review 7 August 2025 at 9:00 a.m. EEST

FY26 Guidance

Group mine and milling outputs to lift, delivering improved free cash flow in FY26 PERTH, Western Australia, Aug. 7, 2025 /CNW/ - Westgold Resources Limited...

Carriage Services Announces Second Quarter 2025 Results, Strategic Acquisitions, and Raises Full-Year 2025 Outlook

Conference call on Thursday, August 7, 2025 at 8:00 a.m. Central Time 
Conference call on Thursday, August 7, 2025 at 8:00 a.m. Central Time

Clinical Trial Site Feasibility: from 6 Months to Minutes with Research Grid’s New Automation Tool

Research Grid (R.grid) launches new Site Feasibility solution to accelerate trial startups and expand global patient accessThe tool uses real-world data paired with Research...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRecruitment

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers